BioCentury
ARTICLE | Clinical News

Cordase: Began Phase II trial

October 23, 2000 7:00 AM UTC

BioSpecifics Technologies Corp. (BSTC), Lynbrook, N.Y. Product: Cordase Business: Biomaterial/Skin/Wound, Musculoskeletal Therapeutic category: Matrix remodeling Target: Collagen Description: Inject...